Ditropan XL (Oxybutynin ER)

Brand Options

arrow pointer

Brand Name : Ditropan XL

Marketing Authorization Holder : Janssen-Cilag

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Oxybutynin ER

Manufactured By : Authorized Indian Generic

Prescription Required

 
 

Product Details

Ditropan XL

Ditropan XL is called Lyrinel in Europe.

Information about Ditropan XL (Oxybutynin ER)

Ditropan XL is an extended-release formulation of oxybutynin, a medication used primarily to treat symptoms of overactive bladder. It is designed to provide a more consistent release of the active ingredient over time compared to immediate-release formulations, which can help manage symptoms with fewer doses throughout the day.

Product Highlights

  • Ditropan XL is indicated for the management of symptoms associated with an overactive bladder, such as:
  • Urgency
  • Frequency
  • Urge urinary incontinence
  • These symptoms can be due to various conditions, including neurological disorders or idiopathic causes.

Key Ingredient

  • Oxybutynin

Key Benefits

  • Provides sustained relief throughout the day with just one dose.
  • Helps decrease the need for frequent urination and urgent trips to the bathroom.
  • Can help patients feel more comfortable and confident by managing urinary symptoms effectively.

Direction of Use

  • Typically, one tablet is taken once daily. It's essential to adhere to the dosage recommended by your healthcare provider.
  • The tablet should be consumed intact with a glass of water. It should not be chewed, crushed, or broken, as this can affect the extended-release mechanism.

Safety Concerns

  • Dry mouth, constipation, dizziness, and blurred vision.
  • In rare cases, may include severe allergic reactions, hallucinations, or significant changes in heart rate.

Avoid Ditropan XL (Oxybutynin ER) If

  • You have a known hypersensitivity or allergy to oxybutynin or any of its components.
  • Ditropan XL may not be recommended due to altered drug metabolism.
  • Avoid if you have conditions like uncontrolled glaucoma, severe gastrointestinal obstruction, or a myasthenia gravis diagnosis, as oxybutynin could exacerbate these conditions.


Image Image Image Image